Form 4: ResMed Executive Justin Leong Sells 48,000 Shares
SEC Form 4 Filing
Justin Leong, President of Asia and Latin America at ResMed Inc., sold 48,000 shares of ReMed Common Stock on August 5, 2024.
Summary
- On August 5, 2024, Justin Leong, President of Asia and Latin America at ResMed Inc., sold 48,000 shares of ReMed Common Stock.
- The sale price was $217.074 per share.
- Following the transaction, Leong directly owns 18,741 shares of ReMed Common Stock.
Sentiment
Score: 5
Explanation: This is a routine disclosure of an insider stock sale. It doesn't inherently indicate positive or negative sentiment, but rather provides information about an executive's transactions.
Industry Context
This is a standard SEC Form 4 filing, which is required when an insider of a publicly traded company buys or sells the company's stock. It provides transparency into the transactions of company executives and directors.
Stakeholder Impact
- The sale of shares by a company executive could be perceived negatively by some shareholders, but it is a common occurrence and doesn't necessarily indicate a problem with the company.
Key Dates
| Date | Description |
|---|---|
| 08/05/2024 | Date of transaction: Justin Leong sold 48,000 shares of ReMed Common Stock. |
| 08/06/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.